Header image

Oral presentations 8: New therapies and management of hypertension

Tracks
Track 4
Wednesday, December 10, 2025
2:00 PM - 3:30 PM

Speaker

Agenda Item Image
Professor Markus Schlaich
Dobney Chair In Clinical Research
Royal Perth Hospital - University of Western Australia

The effect of aprocitentan in patients with very high baseline blood pressure

Abstract document

Biography

Prof Markus Schlaich is a renal physician and a European Society of Hypertension (ESH) accredited hypertension specialist. Markus is Chair of Hypertension Australia and Co-Chair of the National Hypertension Taskforce. He has a strong background in clinical research with a focus on the pathophysiology of hypertension, the role of the sympathetic nervous system, involvement of the kidneys, and hypertension mediated organ damage. He has a specific interest in treatment modalities targeting the sympathetic nervous system and has been a pioneer of renal denervation and other interventional and pharmacological approaches to treat hypertension. He has authored more than 500 articles in peer reviewed journals and serves on the Editorial Board of Hypertension, Journal of Hypertension, and Hypertension Research.
Agenda Item Image
Dr Madeleine Cosgrave
Eastern Health Clinical School, Monash University

Chronic hypertension in young women – are we adequately preparing for pregnancy?

Abstract document

Biography

Madeleine is a renal and obstetric medicine physician at Eastern Health, Melbourne. She is completing a PhD in hypertensive disorders of pregnancy. She is passionate about improving care for women with these disorders and has recently been involved in implementing a new postpartum hypertension surveillance program at Eastern Health.
Agenda Item Image
Dr Alexandra Gallagher
Phd Candidate
University Of Sydney

Australia lacks a high-quality national database system on blood pressure

Abstract document

Biography

Dr Alexandra Gallagher is a Staff Specialist Nephrologist at St George Hospital and PhD candidate at the NHMRC Clinical Trials Centre at the University of Sydney. Her PhD is exploring the efficacy and safety of cardioprotective strategies in high risk patients, including inpatient blood pressure measurement. She is a member of the National Hypertension Taskforce, working group 4 and medical lead for the NSW Ministry of Health's renal Net Zero hub.
Agenda Item Image
Prof James Sharman
Menzies Institute for Medical Research

Improved cardiovascular disease risk management via pathology services: a randomised clinical trial

Abstract document

Biography

James Sharman is a professor of medical research at the Menzies Institute for Medical Research. He heads the Blood Pressure Research Group and is former Deputy Director of the Institute.
Agenda Item Image
Dr Edel O'hagan
Research Fellow
Westmead Applied Research Centre, The University of Sydney

What attributes influence antihypertensive prescribing to older adults? A discrete choice experiment.

Abstract document

Biography

Edel is a postdoctoral researcher focused on improving blood pressure control in older and underserved populations through innovative digital health approaches.
Agenda Item Image
Miss Ngoc Tran
University Of Sydney

Impact of packaging aids on medication errors: a systematic scoping review

Abstract document

Biography

Ngoc Tran is an honours student in the Bachelor of Pharmacy program at the University of Sydney. Her current research focuses on the role of dose administration aids in improving medication safety, particularly for vulnerable patient groups. Her broader research interests include pharmacoepidemiology and the quality use of medicines. She aims to pursue a PhD to build on her research in medication safety, with the goal of improving patient outcomes.
loading